Philip R. Mayeux

6.1k total citations · 2 hit papers
68 papers, 5.1k citations indexed

About

Philip R. Mayeux is a scholar working on Nephrology, Physiology and Molecular Biology. According to data from OpenAlex, Philip R. Mayeux has authored 68 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 20 papers in Physiology and 17 papers in Molecular Biology. Recurrent topics in Philip R. Mayeux's work include Nitric Oxide and Endothelin Effects (20 papers), Acute Kidney Injury Research (17 papers) and Eicosanoids and Hypertension Pharmacology (13 papers). Philip R. Mayeux is often cited by papers focused on Nitric Oxide and Endothelin Effects (20 papers), Acute Kidney Injury Research (17 papers) and Eicosanoids and Hypertension Pharmacology (13 papers). Philip R. Mayeux collaborates with scholars based in United States, United Kingdom and Japan. Philip R. Mayeux's co-authors include Jack Hinson, Laura P. James, Neriman Gökden, Neil R. Pumford, Joseph H. Holthoff, Lee Ann MacMillan-Crow, Perry V. Halushka, Dale E. Mais, Liping Wu and Kathryn A. Seely and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and The FASEB Journal.

In The Last Decade

Philip R. Mayeux

68 papers receiving 4.9k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ACETAMINOPHEN-INDUCED HEPATOTOXICITY

2003 848 citations Laura P. James, Philip R. Mayeux et al. Drug Metabolism and Disposition profile →
The Endothelium in Sepsis

2016 450 citations Can İnce, Philip R. Mayeux et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip R. Mayeux United States	35	1.4k	1.3k	961	759	663	68	5.1k
Daniel J. Antoine United Kingdom	37	1.5k 1.1×	1.6k 1.3×	1.1k 1.2×	197 0.3×	192 0.3×	75	5.6k
Sun‐Mee Lee South Korea	44	1.1k 0.8×	2.1k 1.6×	962 1.0×	95 0.1×	420 0.6×	157	5.3k
Pablo Muriel Mexico	42	1.8k 1.3×	1.4k 1.1×	1.9k 2.0×	103 0.1×	511 0.8×	137	5.8k
Paul H. Guth United States	47	469 0.3×	1.5k 1.2×	555 0.6×	295 0.4×	1.2k 1.8×	231	7.4k
Dale A. Parks United States	47	362 0.3×	2.1k 1.6×	518 0.5×	1.4k 1.9×	1.9k 2.9×	96	8.3k
Yaw L. Siow Canada	41	269 0.2×	1.6k 1.3×	563 0.6×	293 0.4×	533 0.8×	116	4.7k
Kenichi Watanabe Japan	45	247 0.2×	2.1k 1.6×	823 0.9×	236 0.3×	680 1.0×	202	6.0k
Motoharu Kondo Japan	43	537 0.4×	2.2k 1.7×	516 0.5×	206 0.3×	1.3k 2.0×	254	7.6k
Michal L. Schwartzman United States	61	1.7k 1.2×	4.5k 3.5×	562 0.6×	140 0.2×	1.9k 2.9×	258	11.2k
Jinhan He China	35	437 0.3×	1.7k 1.3×	1.6k 1.6×	117 0.2×	1.2k 1.8×	102	4.9k

Countries citing papers authored by Philip R. Mayeux

Since Specialization

Citations

This map shows the geographic impact of Philip R. Mayeux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip R. Mayeux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip R. Mayeux more than expected).

Fields of papers citing papers by Philip R. Mayeux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip R. Mayeux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip R. Mayeux. The network helps show where Philip R. Mayeux may publish in the future.

Co-authorship network of co-authors of Philip R. Mayeux

This figure shows the co-authorship network connecting the top 25 collaborators of Philip R. Mayeux. A scholar is included among the top collaborators of Philip R. Mayeux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip R. Mayeux. Philip R. Mayeux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

İnce, Can, Daniel De Backer, & Philip R. Mayeux. (2020). Microvascular Dysfunction in the Critically Ill. Critical Care Clinics. 36(2). 323–331. 16 indexed citations

Sims, Clark, Sharda P. Singh, & Philip R. Mayeux. (2016). Preclinical Evaluation of the Phosphodiesterase‐4 Inhibitor, Rolipram, in an Infant Model of Sepsis‐Induced Cardiorenal Syndrome. The FASEB Journal. 30(S1). 3 indexed citations

Sims, Charles R., Tom C. Nguyen, & Philip R. Mayeux. (2016). Could Biomarkers Direct Therapy for the Septic Patient?. Journal of Pharmacology and Experimental Therapeutics. 357(2). 228–239. 14 indexed citations

Sims, Clark, Lee Ann MacMillan-Crow, & Philip R. Mayeux. (2014). Targeting mitochondrial oxidants may facilitate recovery of renal function during infant sepsis. Clinical Pharmacology & Therapeutics. 96(6). 662–664. 20 indexed citations

Wang, Zhen, Clark Sims, Naeem K. Patil, Neriman Gökden, & Philip R. Mayeux. (2014). Pharmacologic Targeting of Sphingosine-1-Phosphate Receptor 1 Improves the Renal Microcirculation during Sepsis in the Mouse. Journal of Pharmacology and Experimental Therapeutics. 352(1). 61–66. 38 indexed citations

Pathak, Elina, Lee Ann MacMillan-Crow, & Philip R. Mayeux. (2011). Role of Mitochondrial Oxidants in an In Vitro Model of Sepsis-Induced Renal Injury. Journal of Pharmacology and Experimental Therapeutics. 340(1). 192–201. 32 indexed citations

Herzog, Christian, Randy S. Haun, Varsha Kaushal, et al.. (2009). Meprin A and meprin α generate biologically functional IL-1β from pro-IL-1β. Biochemical and Biophysical Research Communications. 379(4). 904–908. 63 indexed citations

Wu, Liping & Philip R. Mayeux. (2007). Effects of the Inducible Nitric-Oxide Synthase Inhibitor l-N6-(1-Iminoethyl)-lysine on Microcirculation and Reactive Nitrogen Species Generation in the Kidney following Lipopolysaccharide Administration in Mice. Journal of Pharmacology and Experimental Therapeutics. 320(3). 1061–1067. 36 indexed citations

Tiwari, Manish, et al.. (2006). Inducible Nitric Oxide Synthase and Apoptosis in Murine Proximal Tubule Epithelial Cells. Toxicological Sciences. 91(2). 493–500. 24 indexed citations

10.

Mayeux, Philip R., et al.. (2005). Agonist-Directed Trafficking of Response by Endocannabinoids Acting at CB2 Receptors. Journal of Pharmacology and Experimental Therapeutics. 315(2). 828–838. 107 indexed citations

11.

Tiwari, Manish, Robert W. Brock, Judit Megyesi, Gur P. Kaushal, & Philip R. Mayeux. (2005). Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspases. American Journal of Physiology-Renal Physiology. 289(6). F1324–F1332. 88 indexed citations

12.

James, Laura P., Philip R. Mayeux, & Jack Hinson. (2003). ACETAMINOPHEN-INDUCED HEPATOTOXICITY. Drug Metabolism and Disposition. 31(12). 1499–1506. 848 indexed citations breakdown →

13.

Muldrew, Kenneth L., Laura P. James, Sandra McCullough, et al.. (2002). Determination of Acetaminophen-Protein Adducts in Mouse Liver and Serum and Human Serum after Hepatotoxic Doses of Acetaminophen Using High-Performance Liquid Chromatography with Electrochemical Detection. Drug Metabolism and Disposition. 30(4). 446–451. 161 indexed citations

14.

Walker, Lisa, Sudhir V. Shah, & Philip R. Mayeux. (2000). Lack of a role for inducible nitric oxide synthase in an experimental model of nephrotic syndrome. Biochemical Pharmacology. 60(1). 137–143. 9 indexed citations

15.

Mayeux, Philip R.. (1997). PATHOBIOLOGY OF LIPOPOLYSACCHARIDE. Journal of Toxicology and Environmental Health. 51(5). 415–435. 187 indexed citations

16.

Proksch, Joel W., et al.. (1996). Nitric oxide generation by renal proximal tubules: role of nitric oxide in the cytotoxicity of lipid A.. Journal of Pharmacology and Experimental Therapeutics. 279(1). 91–96. 16 indexed citations

17.

Proksch, Joel W., et al.. (1996). Effects of lipid A on calcium homeostasis in renal proximal tubules.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 555–560. 15 indexed citations

18.

Mayeux, Philip R., Philip J. Kadowitz, & Dennis B. McNamara. (1989). Differential effects of ibuprofen, indomethacin, and meclofenamate on prostaglandin endoperoxide H2 metabolism. Molecular and Cellular Biochemistry. 87(1). 41–46. 6 indexed citations

19.

Rush, Daniel S., Morris D. Kerstein, J. A. Bellan, et al.. (1988). Prostacyclin, thromboxane A2, and prostaglandin E2 formation in atherosclerotic human carotid artery.. Arteriosclerosis An Official Journal of the American Heart Association Inc. 8(1). 73–78. 23 indexed citations

20.

Mayeux, Philip R., K. C. AGRAWAL, Jen‐sie Tou, et al.. (1988). The pharmacological effects of allicin, a constituent of garlic oil. Inflammation Research. 25(1-2). 182–190. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact